The Patent Finder

Terms ending in 2041

AstraZeneca AB

Every in-force patent on AstraZeneca AB's record whose computed term ends in 2041, whoever holds it now. Soonest term end first, then patent number.
PatentTitleHolderStatusExpiresConfidence
US 12,007,393Methods Based on the Detection of RAD51 Foci in Tumor Cells
In force
 · High confidence
Fundació Privada Institut d'Investigació Oncològica de Vall Hebron, AstraZeneca UK Limited and Xentech SASIn forceHigh confidence
US 11,884,671Purinone Compounds and Their Use in Treating Cancer
In force
 · High confidence
AstraZeneca AB and Cancer Research Technology LimitedIn forceHigh confidence
US 12,213,988Methods of Treating Chronic Kidney Disease with Dapagliflozin
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 12,409,186Methods of Treating Chronic Kidney Disease with Dapagliflozin
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 11,964,097Inhaler
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US D1,125,537Medical Injector
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US D1,126,392Inhaler
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,134,613Improved Method for the Manufacture of 3-[(1S)-1-imidazo[1,2-a]pyridin-6-ylethyl]-5-(1-methylpyrazol-4-yl)triazolo[4,5-b]pyrazine and polymorphic forms thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
US 12,410,254Treatment of Cardiometabolic Disease with Inhibitors of Type I Interferon Signalling
In force
 · Medium confidence
AstraZeneca ABIn forceMedium confidence
US 11,952,392Arginase Inhibitors and Methods of Use thereof
In force
 · High confidence
AstraZeneca ABIn forceHigh confidence
21 more term ends in 2041 · Pro
10 of 31 patents shown. Soonest term end first, then patent number.
Pro members see all 31.
Upgrade to Pro
27 of these are in force and held by AstraZeneca AB.
Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 16, 2026 · includes USPTO assignment & status data published Nov 16, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited